Pathogenesis of severe acute respiratory syndrome
- PMID: 15950449
- PMCID: PMC7127490
- DOI: 10.1016/j.coi.2005.05.009
Pathogenesis of severe acute respiratory syndrome
Abstract
Severe acute respiratory syndrome (SARS) is a zoonotic infectious disease caused by a novel coronavirus (CoV). The tissue tropism of SARS-CoV includes not only the lung, but also the gastrointestinal tract, kidney and liver. Angiotensin-converting enzyme 2 (ACE2), the C-type lectin CD209L (also known L-SIGN), and DC-SIGN bind SARS-CoV, but ACE2 appears to be the key functional receptor for the virus. There is a prominent innate immune response to SARS-CoV infection, including acute-phase proteins, chemokines, inflammatory cytokines and C-type lectins such as mannose-binding lectin, which plays a protective role against SARS. By contrast there may be a lack of type 1 interferon response. Moreover, lymphopenia with decreased numbers of CD4+ and CD8+ T cells is common during the acute phase. Convalescent patients have IgG-class neutralizing antibodies that recognize amino acids 441-700 of the spike protein (S protein) as the major epitope.
Figures
Similar articles
-
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.mBio. 2018 Oct 9;9(5):e01753-18. doi: 10.1128/mBio.01753-18. mBio. 2018. PMID: 30301856 Free PMC article.
-
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53. doi: 10.1073/pnas.0403812101. Epub 2004 Oct 20. Proc Natl Acad Sci U S A. 2004. PMID: 15496474 Free PMC article.
-
How the SARS coronavirus causes disease: host or organism?J Pathol. 2006 Jan;208(2):142-51. doi: 10.1002/path.1897. J Pathol. 2006. PMID: 16362992 Free PMC article. Review.
-
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro.J Virol. 2006 Mar;80(6):2684-93. doi: 10.1128/JVI.80.6.2684-2693.2006. J Virol. 2006. PMID: 16501078 Free PMC article.
-
The Immunobiology of SARS*.Annu Rev Immunol. 2007;25:443-72. doi: 10.1146/annurev.immunol.25.022106.141706. Annu Rev Immunol. 2007. PMID: 17243893 Review.
Cited by
-
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.Antibodies (Basel). 2020 Jul 16;9(3):33. doi: 10.3390/antib9030033. Antibodies (Basel). 2020. PMID: 32708525 Free PMC article.
-
Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table.Int Immunopharmacol. 2022 Dec;113(Pt A):109325. doi: 10.1016/j.intimp.2022.109325. Epub 2022 Oct 14. Int Immunopharmacol. 2022. PMID: 36252475 Free PMC article. Review.
-
Potential for the replication of the betanodavirus redspotted grouper nervous necrosis virus in human cell lines.Arch Virol. 2008;153(1):15-24. doi: 10.1007/s00705-007-1051-9. Epub 2007 Sep 28. Arch Virol. 2008. PMID: 17906832 Free PMC article.
-
Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.Semin Respir Crit Care Med. 2013 Aug;34(4):475-86. doi: 10.1055/s-0033-1351122. Epub 2013 Aug 11. Semin Respir Crit Care Med. 2013. PMID: 23934716 Free PMC article. Review.
-
Interferon and cytokine responses to SARS-coronavirus infection.Cytokine Growth Factor Rev. 2008 Apr;19(2):121-32. doi: 10.1016/j.cytogfr.2008.01.001. Epub 2008 Mar 5. Cytokine Growth Factor Rev. 2008. PMID: 18321765 Free PMC article. Review.
References
-
- Peiris J.S.M., Lai S.T., Poon L.L.M., Guan Y., Yam L.Y.C., Lim W., Nicholls J., Yee W.K.S., Yan W.W., Cheung M.T. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319–1325. - PMC - PubMed
-
The first report of the isolation and characterization of the etiological agent of SARS. Demonstrated the consistent detection of the virus and immune response to it in a series of patients with the disease and the absence of both virus and antibody in controls.
-
- Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Corner J.A., Lim W. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. - PubMed
-
- Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A.M. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. - PubMed
-
- Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous